Literature DB >> 31632664

Nonliver Comorbidities in Patients With Chronic Hepatitis B.

Mike T Wei1, Linda Henry1, Mindie H Nguyen1.   

Abstract

Entities:  

Year:  2019        PMID： 31632664      PMCID： PMC6784802          DOI： 10.1002/cld.829

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  46 in total

Review 1.  Extrahepatic manifestations of chronic viral hepatitis.

Authors:  N T Pyrsopoulos; K R Reddy
Journal:  Curr Gastroenterol Rep       Date:  2001-02

Review 2.  Hepatitis B seropositivity and risk of developing multiple myeloma or Hodgkin lymphoma: A meta-analysis of observational studies.

Authors:  Samir Dalia; Kelli Dunker; Lubomir Sokol; Rahul Mhaskar
Journal:  Leuk Res       Date:  2015-09-09       Impact factor: 3.156

3.  Hepatitis B and renal function: A matched study comparing non-hepatitis B, untreated, treated and cirrhotic hepatitis patients.

Authors:  Vinh Vu; Sam Trinh; An Le; Tiffani Johnson; Joseph Hoang; Donghak Jeong; Linda Henry; Scott Barnett; Ramsey Cheung; Mindie H Nguyen
Journal:  Liver Int       Date:  2018-12-18       Impact factor: 5.828

4.  Association between HBsAg positivity and pancreatic cancer: a meta-analysis.

Authors:  Shounak Majumder; Bruno Bockorny; William L Baker; Constantin A Dasanu
Journal:  J Gastrointest Cancer       Date:  2014-09

5.  Increased prevalence of carotid atherosclerosis in hepatitis B virus carriers.

Authors:  Nobukazu Ishizaka; Yuko Ishizaka; Eiko Takahashi; Ei-ichi Toda Ei; Hideki Hashimoto; Minoru Ohno; Ryozo Nagai; Minoru Yamakado
Journal:  Circulation       Date:  2002-03-05       Impact factor: 29.690

6.  Sociocultural factors that potentially affect the institution of prevention and treatment strategies for prevention of hepatitis B in Chinese Canadians.

Authors:  Harry Wu; Colina Yim; Alex Chan; Michael Ho; Jenny Heathcote
Journal:  Can J Gastroenterol       Date:  2009-01       Impact factor: 3.522

7.  Healthcare resource utilization and costs by disease severity in an insured national sample of US patients with chronic hepatitis B.

Authors:  Mindie H Nguyen; A Burak Ozbay; Iris Liou; Nicole Meyer; Stuart C Gordon; Geoffrey Dusheiko; Joseph K Lim
Journal:  J Hepatol       Date:  2018-10-01       Impact factor: 25.083

Review 8.  Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013.

Authors:  Aparna Schweitzer; Johannes Horn; Rafael T Mikolajczyk; Gérard Krause; Jördis J Ott
Journal:  Lancet       Date:  2015-07-28       Impact factor: 79.321

9.  AASLD guidelines for treatment of chronic hepatitis B.

Authors:  Norah A Terrault; Natalie H Bzowej; Kyong-Mi Chang; Jessica P Hwang; Maureen M Jonas; M Hassan Murad
Journal:  Hepatology       Date:  2015-11-13       Impact factor: 17.425

10.  13-year nationwide cohort study of chronic kidney disease risk among treatment-naïve patients with chronic hepatitis B in Taiwan.

Authors:  Yi-Chun Chen; Yu-Chieh Su; Chung-Yi Li; Shih-Kai Hung
Journal:  BMC Nephrol       Date:  2015-07-22       Impact factor: 2.388
View more
  1 in total

1.  Prevalence and Risk Factors of Cardiovascular Disease in Patients with Chronic Hepatitis B.

Authors:  Ho Soo Chun; Jae Seung Lee; Hye Won Lee; Beom Kyung Kim; Jun Yong Park; Do Young Kim; Sang Hoon Ahn; Seung Up Kim
Journal:  Dig Dis Sci       Date:  2021-09-02       Impact factor: 3.487
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.